QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
SV investment has resulted in the approval of 24 novel therapeutics
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
Merck to Acquire Caraway Therapeutics, Inc.
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group
- 25 April 2024Portfolio NewsCerevance Adds $47 Million in Series B-1 Extension to Advance Robust Clinical Pipeline
- 24 April 2024Portfolio NewsHarness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board Chair
- 15 April 2024Portfolio NewsPulmocide Announces Successful Results from the OPERA-S Study: a Phase 2 Safety Study with Inhaled Opelconazole
- 15 April 2024Portfolio NewsAviadoBio Announces First Patient Treated in ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
- 12 April 2024Portfolio NewsPrilenia to Present Latest Research from its Pridopidine Programs for Huntington Disease and ALS at AAN 2024
- 10 April 2024Portfolio NewsSitryx nominates SYX-5219 a novel, oral and targeted PKM2 activator for clinical development in atopic dermatitis
- 7 April 2024Portfolio NewsRibometrix Presents First c-MYC Data Validating RNA-Targeting Platform and Demonstrates Synergistic Potential of eIF4E Program at AACR 2024
- 27 March 2024Portfolio NewsCumulus Neuroscience Receives Innovate UK Small Business Research Initiative (SBRI) Grant Focused on Clinical Biomarker Tools and Technologies for Dementia
- 26 March 2024SV NewsSV Biotech launches its inaugural ESG and Impact Report
- 26 March 2024SV NewsDementia Discovery Fund Look Ahead: 2024 is shaping up to be another big year in the fight against dementia
- 21 March 2024SV NewsUK dementia adviser [Ruth McKernan] wants half a million volunteers for clinical trials
- 14 March 2024Portfolio NewsCumulus Neuroscience Announces First Patient Enrolled in AccelADx Electroencephalogram (EEG) Study for Early Detection of Alzheimer's Dementia